Economic development creates opportunities to grow state, local and metro areas, which are essential for economic growth, improved quality of life and community development. Biotechnology articles below.
Industry analysts are predicting that 2018 will turn out to be a banner year for merger and acquisition activity in the biotech/pharma sector, with up to $200 billion in assets changing hands.
The March / April 2018 Issue features the emerging cybersecurity sector, an exclusive interview with Kentucky Gov. Matt Bevin, plus a look at biopharm, robots, STEM, data centers, and retail.
A slow start and a dearth of mergers and acquisitions made 2016 a tough year for biotech, but new gene and immuno-therapies are leading the way for a much stronger performance when 2017 results are in.
The 30,000-square foot facility — a collaborative effort by Johnson & Johnson Innovation, New York State and New York Genome Center — will have capacity for up to 30 life science startups focused on biotech, pharmaceutical, medical devices and consumer health.
The 100,000-square-foot building is the latest addition to the 152-acre HudsonAlpha Institute for Biotechnology campus in Huntsville, AL, and will house a mix of research laboratories and life sciences companies.
CTD Holdings will invest $2.75M and create 51 jobs at its new corporate headquarters in Jupiter, FL.
The 40 growing technology and biotech companies will share the New Jersey Technology Business Tax Certificate Transfer Program funds in FY2017.
A $1.8 million specialized biotech startup and a $10 million expansion of Coldstream Labs’ pharmaceutical plant are the most recent additions to Lexington’s growing biotech cluster.
The world's biggest biotechnology success story is having some unintended consequences.
The growing Montgomery County, MD clinical stage vaccine company is developing promising vaccines for RSV, influenza and Ebola.
A $2.8-million investment from Innovate NY—matched by $21.5 million in private equity—is spurring the development of a biotech cluster in New York City.
The Global Biotech Industry is the focus of Business Facilities' March/April 2016 issue, along with our annual Economic Development Awards. Plus, a look at the Aerospace Industry.
The global life sciences industry has adopted an attitude of cautious optimism, expecting reliable growth that will fall short of pre-recession investment surges.
Technology and biotechnology companies around New Jersey invested more than $51 million in 2015.
The New Jersey Economic Development Authority (NJ EDA) has approved 41 companies to share a total of $47.4 million through the state’s Technology Business Tax Certificate Transfer (NOL) Program in FY 2016.
Greater Phoenix, Arizona is a high-tech hub and a growth juggernaut, with unparalleled market access to the Mountain and Western regions of the U.S.
New Jersey Lt. Governor Kim Guadagno discusses the Garden State's growing biotech/pharma industry and workforce training programs.
JLL’s 2015 Life Sciences Outlook Report identifies top global destinations for talent, sales, science and the trends driving international growth
The global biotechnology industry is the focus of Business Facilities' May/June 2015 issue, which also includes a focus on high-tech manufacturing and coverage of the water resources industry.
The biotech playing field is leveling, Europe is in crisis and the data center industry is growing by gigabytes. Go figure. From the May/June 2012 issue